Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
Titel:
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
Auteur:
Mallory, Raburn M Formica, Neil Pfeiffer, Susan Wilkinson, Bethanie Marcheschi, Alex Albert, Gary McFall, Heather Robinson, Michelle Plested, Joyce S Zhu, Mingzhu Cloney-Clark, Shane Zhou, Bin Chau, Gordon Robertson, Andreana Maciejewski, Sonia Hammond, Holly L Baracco, Lauren Logue, James Frieman, Matthew B Smith, Gale Patel, Nita Glenn, Gregory M